Hedge Fund - Eversept Partners
Glaxosmithkline Plc (GSK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $131,413,518 | 6.62% | 2,679,721 | $46.64 |
| 2 | 2025 - Q3 (2025-09-30) | $91,518,449 | 6.31% | 2,120,446 | $39.06 |
| 3 | 2025 - Q2 (2025-06-30) | $86,107,699 | 7.92% | 2,242,388 | $38.21 |
| 4 | 2025 - Q1 (2025-03-31) | $101,624,550 | 10.32% | 2,623,246 | $36.61 |
| 5 | 2024 - Q4 (2024-12-31) | $123,840,994 | 10.99% | 3,661,768 | $36.00 |
| 6 | 2024 - Q3 (2024-09-30) | $165,858,581 | 11.36% | 4,057,206 | $40.91 |
| 7 | 2024 - Q2 (2024-06-30) | $133,521,080 | 9.14% | 3,468,080 | $42.07 |
| 8 | 2024 - Q1 (2024-03-31) | $161,705,383 | 10.78% | 3,771,994 | $41.24 |
| 9 | 2023 - Q4 (2023-12-31) | $110,177,675 | 9.67% | 2,972,954 | $35.90 |
| 10 | 2023 - Q3 (2023-09-30) | $118,151,148 | 9.99% | 3,259,342 | $35.49 |
| 11 | 2023 - Q2 (2023-06-30) | $103,772,185 | 8.67% | 2,881,012 | $35.87 |
| 12 | 2023 - Q1 (2023-03-31) | $133,929,238 | 9.33% | 3,731,499 | $34.99 |
| 13 | 2022 - Q4 (2022-12-31) | $123,825,940 | 10.84% | 3,490,457 | $33.31 |
| 14 | 2022 - Q3 (2022-09-30) | $87,268,411 | 7.56% | 2,939,070 | $36.31 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
613.0000:500.0000 on 2022-07-22
-
4.0000:5.0000 on 2022-07-19
Hedge Fund Resource Center